{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:55:56Z","timestamp":1793436956154,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fertility preservation for adolescent pubescent girls is a concern of the healthcare system and parents. Oocyte cryopreservation is regarded as a standard medical intervention for patients with a minimum age of 18 years. Evidence suggests that mature oocyte cryopreservation is possible for adolescent pubescent girls, although, ovarian stimulation for these patients remains a challenge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Cases presentation<\/jats:title>\n                <jats:p>This case series is the first report regarding ovarian stimulation with oocyte cryopreservation in younger than 18 years cancerous girls, who refer to ROYAN institute, Tehran, Iran, prior to the start of the treatment of cancer (November 2015 to February 2021). The oocyte cryopreservation was carried out in the 7 patients (five patients with Hodgkin lymphoma, one patient with Ewing sarcoma, and one patient with osteogenic tumor), the embryo cryopreservation in one patient with dysgerminoma, and the oocyte and embryo cryopreservation in one patient with germ cell tumor. No oocytes were retrieved after ovarian stimulation in the patient with medulloblastoma. For one of the patients with Hodgkin lymphoma, half of the tissues of one ovary were cryopreserved prior to ovarian stimulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Oocyte cryopreservation is a feasible option of fertility preservation in the adolescent\u2019s patients with cancer. However, only if reported acceptable fertilization rates, as well as the successful cases of live birth from oocyte cryopreservation at the ages under 18, this option of preserving fertility can be applied to this age range.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-024-01352-0","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:05:08Z","timestamp":1707131108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Controlled ovarian stimulation in cancer patients under 18 years old; a case series"],"prefix":"10.1186","volume":"17","author":[{"given":"Azar","family":"Yahyaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Moridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firouzeh","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"issue":"5","key":"1352_CR1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/aogs.13559","volume":"98","author":"KA Rodriguez-Wallberg","year":"2019","unstructured":"Rodriguez-Wallberg KA, Marklund A, Lundberg F, Wikander I, Milenkovic M, Anastacio A, et al. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients\u2019 choices and benefit of the chosen methods after long-term follow up. Acta obstetricia et gynecologica Scandinavica. 2019;98(5):604\u201315. https:\/\/doi.org\/10.1111\/aogs.13559.","journal-title":"Acta obstetricia et gynecologica Scandinavica"},{"issue":"2","key":"1352_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/cancers13020202","volume":"13","author":"K Michalczyk","year":"2021","unstructured":"Michalczyk K, Cymbaluk-P\u0142oska A. Fertility Preservation and Long-Term Monitoring of Gonadotoxicity in Girls, Adolescents and Young Adults Undergoing Cancer Treatment. Cancers. 2021;13(2):202. https:\/\/doi.org\/10.3390\/cancers13020202.","journal-title":"Cancers"},{"issue":"2","key":"1352_CR3","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","volume":"22","author":"RL Mulder","year":"2021","unstructured":"Mulder RL, Font-Gonzalez A, Hudson MM, Van Santen HM, Loeffen EA, Burns KC, et al. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22(2):e45\u201356. https:\/\/doi.org\/10.1016\/S1470-2045(20)30594-5.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1352_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/03009734.2020.1737601","volume":"125","author":"KA Rodriguez-Wallberg","year":"2020","unstructured":"Rodriguez-Wallberg KA, Anastacio A, Vonheim E, Deen S, Malmros J, Borgstr\u00f6m B. Fertility preservation for young adults, adolescents, and children with cancer. Upsala J Med Sci. 2020;125(2):112\u201320. https:\/\/doi.org\/10.1080\/03009734.2020.1737601.","journal-title":"Upsala J Med Sci"},{"key":"1352_CR5","doi-asserted-by":"publisher","unstructured":"Medicine PCotASfR. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022-33. \nhttps:\/\/doi.org\/10.1016\/j.fertnstert.2019.09.013.","DOI":"10.1016\/j.fertnstert.2019.09.013"},{"key":"1352_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/78659c74-03b7-4024-85ad-c628e2542107","author":"E Rowell","year":"2020","unstructured":"Rowell E, Duncan F, Laronda M. ASRM removes the experimental label from Ovarian Tissue Cryopreservation (OTC): pediatric research must continue. Fertil Steril Dialog. 2020. https:\/\/doi.org\/10.1016\/78659c74-03b7-4024-85ad-c628e2542107.","journal-title":"Fertil Steril Dialog"},{"issue":"4","key":"1352_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jpag.2019.03.001","volume":"32","author":"HS Hipp","year":"2019","unstructured":"Hipp HS, Shandley LM, Schirmer DA, McKenzie L, Kawwass JF. Oocyte cryopreservation in adolescent women. J Pediatr Adolesc Gynecol. 2019;32(4):377\u201382. https:\/\/doi.org\/10.1016\/j.jpag.2019.03.001.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"1352_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10815-010-9487-3","volume":"28","author":"TJ Kim","year":"2011","unstructured":"Kim TJ, Hong SW. Successful live birth from vitrified oocytes after 5 years of cryopreservation. J Assist Reprod Genet. 2011;28(1):73\u20136. https:\/\/doi.org\/10.1007\/s10815-010-9487-3.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"1352_CR9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1080\/01443615.2017.1398222","volume":"38","author":"WH Kutteh","year":"2018","unstructured":"Kutteh WH, Klosky JL, Green DM, Sparrow CK, Kutteh MA, Robinson GW, et al. Ovulation induction and oocyte retrieval for fertility preservation in young adolescents newly diagnosed with medulloblastoma: a case series. J Obstet Gynaecol. 2018;38(6):878\u20139. https:\/\/doi.org\/10.1080\/01443615.2017.1398222.","journal-title":"J Obstet Gynaecol"},{"issue":"7","key":"1352_CR10","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/humrep\/dew084","volume":"31","author":"SA Lavery","year":"2016","unstructured":"Lavery SA, Islam R, Hunt J, Carby A, Anderson RA. The medical and ethical challenges of fertility preservation in teenage girls: a case series of sickle cell anaemia patients prior to bone marrow transplant. Hum Reprod. 2016;31(7):1501\u20137. https:\/\/doi.org\/10.1093\/humrep\/dew084.","journal-title":"Hum Reprod"},{"issue":"3","key":"1352_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10815-019-01639-y","volume":"37","author":"SL Manuel","year":"2020","unstructured":"Manuel SL, Moravek MB, Confino R, Smith KN, Lawson AK, Klock SC, et al. Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population. J Assist Reprod Genet. 2020;37(3):699\u2013708. https:\/\/doi.org\/10.1007\/s10815-019-01639-y.","journal-title":"J Assist Reprod Genet"},{"key":"1352_CR12","unstructured":"Nagashima T, Muroi K, Kawano-Yamamoto C, Miyoshi T, Ohmine K, Toshima M, et al. Autologous gamete cryopreservation before hemopoietic stem cell transplantation. Med Sci Monit. 2005;11(3):CR91-CR4."},{"key":"1352_CR13","doi-asserted-by":"publisher","unstructured":"Noyes N, Perretta RC, Fino ME, Matulewicz T, Barakat R. Use of hormone suppression then oocyte freezing to preserve reproductive capability in an adolescent girl with ovarian luteinized thecoma associated with sclerosing peritonitis. Fertil Steril. 2009;92(1):393. e11-. e14. \nhttps:\/\/doi.org\/10.1016\/j.fertnstert.2009.01.145.","DOI":"10.1016\/j.fertnstert.2009.01.145"},{"issue":"6","key":"1352_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jpag.2014.01.003","volume":"27","author":"K Oktay","year":"2014","unstructured":"Oktay K, Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. J Pediatr Adolesc Gynecol. 2014;27(6):342\u20136. https:\/\/doi.org\/10.1016\/j.jpag.2014.01.003.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"1352_CR15","doi-asserted-by":"publisher","unstructured":"Oktay K, Rodriguez-Wallberg KA, Sahin G. Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure. Fertility and sterility. 2010;94(2):753. e15-. e19. \nhttps:\/\/doi.org\/10.1016\/j.fertnstert.2010.01.044.","DOI":"10.1016\/j.fertnstert.2010.01.044"},{"issue":"1","key":"1352_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14647273.2017.1347288","volume":"21","author":"VL Peddie","year":"2018","unstructured":"Peddie VL, Maheshwari A. Successful controlled ovarian stimulation and vitrification of oocytes in an adolescent diagnosed with myelodysplastic\/pre-malignant clone with monosomy 7. Hum Fertil. 2018;21(1):39\u201344. https:\/\/doi.org\/10.1080\/14647273.2017.1347288.","journal-title":"Hum Fertil"},{"issue":"5","key":"1352_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.fertnstert.2012.07.1056","volume":"98","author":"DE Reichman","year":"2012","unstructured":"Reichman DE, Davis OK, Zaninovic N, Rosenwaks Z, Goldschlag DE. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril. 2012;98(5):1225\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.07.1056.","journal-title":"Fertil Steril"},{"key":"1352_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fpubh.2014.00246","volume":"2","author":"K Coyne","year":"2014","unstructured":"Coyne K, Purdy M, O\u2019Leary K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and considerations in optimizing ovarian stimulation protocols in oncofertility patients. Front Public Health. 2014;2:246.","journal-title":"Front Public Health"},{"issue":"5","key":"1352_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.fertnstert.2012.07.1093","volume":"98","author":"D Stoop","year":"2012","unstructured":"Stoop D, De Vos M, Tournaye H, Devroey P. Fertility preservation utilizing controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril. 2012;98(5):1121\u20132. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.07.1093.","journal-title":"Fertil Steril"},{"issue":"4","key":"1352_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00737-016-0604-x","volume":"19","author":"V Ehrbar","year":"2016","unstructured":"Ehrbar V, Urech C, Alder J, Harringer K, D\u00e4llenbach RZ, Rochlitz C, et al. Decision-making about fertility preservation\u2014qualitative data on young cancer patients\u2019 attitudes and needs. Arch Women\u2019s Mental Health. 2016;19(4):695\u20139. https:\/\/doi.org\/10.1007\/s00737-016-0604-x.","journal-title":"Arch Women's Mental Health"},{"issue":"19","key":"1352_CR21","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","volume":"36","author":"K Oktay","year":"2018","unstructured":"Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994\u20132001. https:\/\/doi.org\/10.1200\/JCO.2018.78.1914.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1352_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jadohealth.2018.10.297","volume":"64","author":"MB Moravek","year":"2019","unstructured":"Moravek MB, Appiah LC, Anazodo A, Burns KC, Gomez-Lobo V, Hoefgen HR, et al. Development of a pediatric fertility preservation program: a report from the pediatric initiative network of the oncofertility consortium. J Adolesc Health. 2019;64(5):563\u201373. https:\/\/doi.org\/10.1016\/j.jadohealth.2018.10.297.","journal-title":"J Adolesc Health"},{"issue":"1","key":"1352_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2584-7","volume":"16","author":"I Ben-Aharon","year":"2016","unstructured":"Ben-Aharon I, Abir R, Perl G, Stein J, Gilad G, Toledano H, et al. Optimizing the process of fertility preservation in pediatric female cancer patients\u2013a multidisciplinary program. BMC Cancer. 2016;16(1):1\u20139. https:\/\/doi.org\/10.1186\/s12885-016-2584-7.","journal-title":"BMC Cancer"},{"key":"1352_CR24","doi-asserted-by":"publisher","unstructured":"Filippi F, Meazza C, Paffoni A, Raspagliesi F, Terenziani M, Somigliana E. Egg freezing in childhood and young adult cancer survivors. Pediatrics. 2016;138(4). \nhttps:\/\/doi.org\/10.1542\/peds.2016-0291.","DOI":"10.1542\/peds.2016-0291"},{"issue":"1","key":"1352_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.fertnstert.2011.10.014","volume":"97","author":"S Friedler","year":"2012","unstructured":"Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97(1):125\u201333. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.10.014.","journal-title":"Fertil Steril"},{"issue":"7","key":"1352_CR26","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.fertnstert.2013.02.004","volume":"99","author":"JA Garcia-Velasco","year":"2013","unstructured":"Garcia-Velasco JA, Domingo J, Cobo A, Mart\u00ednez M, Carmona L, Pellicer A. Five years\u2019 experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril. 2013;99(7):1994\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.02.004.","journal-title":"Fertil Steril"},{"issue":"4","key":"1352_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jadohealth.2011.01.005","volume":"49","author":"GP Quinn","year":"2011","unstructured":"Quinn GP, Murphy D, Knapp C, Stearsman DK, Bradley-Klug KL, Sawczyn K, et al. Who decides? Decision making and fertility preservation in teens with cancer: a review of the literature. J Adolesc Health. 2011;49(4):337\u201346. https:\/\/doi.org\/10.1016\/j.jadohealth.2011.01.005.","journal-title":"J Adolesc Health."},{"issue":"6","key":"1352_CR28","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.fertnstert.2013.03.014","volume":"99","author":"RA Anderson","year":"2013","unstructured":"Anderson RA, Wallace WHB. Antim\u00fcllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertil Steril. 2013;99(6):1469\u201375. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.03.014.","journal-title":"Fertil Steril"},{"issue":"3","key":"1352_CR29","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.fertnstert.2012.07.187","volume":"98","author":"S Beall","year":"2012","unstructured":"Beall S, Moon K, Widra E, Segars J, Chang F, Richter K. Human chorionic gonadotropin (hCG) re-trigger following a poor response to leuprolide acetate (LA) trigger is not associated with poor in vitro fertilization (IVF) treatment outcomes. Fertil Steril. 2012;98(3):S52. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.07.187.","journal-title":"Fertil Steril"},{"issue":"2","key":"1352_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.fertnstert.2010.09.009","volume":"95","author":"BS Shapiro","year":"2011","unstructured":"Shapiro BS, Daneshmand ST, Restrepo H, Garner FC, Aguirre M, Hudson C. Efficacy of induced luteinizing hormone surge after \u201ctrigger\u201d with gonadotropin-releasing hormone agonist. Fertil Steril. 2011;95(2):826\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.09.009.","journal-title":"Fertil Steril"},{"issue":"19","key":"1352_CR31","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","volume":"31","author":"AW Loren","year":"2013","unstructured":"Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500. https:\/\/doi.org\/10.1200\/JCO.2013.49.2678.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1352_CR32","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/humrep\/des131","volume":"27","author":"D Stoop","year":"2012","unstructured":"Stoop D, Ermini B, Polyzos N, Haentjens P, De Vos M, Verheyen G, et al. Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles. Hum Reprod. 2012;27(7):2030\u20135. https:\/\/doi.org\/10.1093\/humrep\/des131.","journal-title":"Hum Reprod"},{"issue":"6","key":"1352_CR33","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.fertnstert.2012.11.057","volume":"99","author":"K Chung","year":"2013","unstructured":"Chung K, Donnez J, Ginsburg E, Meirow D. Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients. Fertil steril. 2013;99(6):1534\u201342. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.11.057.","journal-title":"Fertil steril"},{"issue":"6","key":"1352_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","volume":"29","author":"Y Kuang","year":"2014","unstructured":"Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, et al. Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol). Reprod Biomed Online. 2014;29(6):684\u201391. https:\/\/doi.org\/10.1016\/j.rbmo.2014.08.009.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"1352_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.rbmo.2014.08.010","volume":"29","author":"R Moffat","year":"2014","unstructured":"Moffat R, Pirtea P, Gayet V, Wolf JP, Chapron C, de Ziegler D. Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited. Reprod Biomed Online. 2014;29(6):659\u201361. https:\/\/doi.org\/10.1016\/j.rbmo.2014.08.010.","journal-title":"Reprod Biomed Online."},{"issue":"14","key":"1352_CR36","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2217\/fon-2016-0181","volume":"12","author":"S-Y Kim","year":"2016","unstructured":"Kim S-Y, Lee JR. Fertility preservation option in young women with ovarian cancer. Future Oncol. 2016;12(14):1695\u20138. https:\/\/doi.org\/10.2217\/fon-2016-0181.","journal-title":"Future Oncol"},{"issue":"3","key":"1352_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jpedsurg.2003.11.027","volume":"39","author":"D Billmire","year":"2004","unstructured":"Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M, et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg. 2004;39(3):424\u20139. https:\/\/doi.org\/10.1016\/j.jpedsurg.2003.11.027.","journal-title":"J Pediatr Surg"},{"issue":"1","key":"1352_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-014-0080-8","volume":"7","author":"M-M Dolmans","year":"2014","unstructured":"Dolmans M-M, Marotta M-L, Pirard C, Donnez J, Donnez O. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res. 2014;7(1):1\u20135. https:\/\/doi.org\/10.1186\/s13048-014-0080-8.","journal-title":"J Ovarian Res"},{"issue":"1","key":"1352_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.fertnstert.2010.07.1074","volume":"95","author":"C Huober-Zeeb","year":"2011","unstructured":"Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, et al. Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. Fertil Steril. 2011;95(1):342\u20134. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.07.1074.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01352-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:14:48Z","timestamp":1707131688000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01352-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01352-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"11 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All he procedures performed in studies involving human participants were in accordance with the ethical standards committee of the Royan Institute and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.Ethics Approval Code: IR.ACECR.ROYAN.REC. 1400.080.Informed consent was obtained from all the individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent to publish this information was obtained from the parents of the study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}